Neisseria Meningitidis Infection - 19 Studies Found
| Completed |
: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine : Meningococcal Disease : 2009-12-04 :
|
| Completed |
: A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive. : Prevention of the Meningococcal Disease : 2013-07-26 : Biological: rMenB+OMV NZ Recombinant MenB with Outer Member Vesicle (OMV) from the New Zealand strain |
| Completed |
: South Australian Meningococcal B Vaccine Herd Immunity Study : Meningococcal Disease : 2017-03-17 : Biological: Licensed 4CMenB vaccine Two doses (0.5 mL each) of Bexsero ® vaccine at least 1 month t |
| Completed |
: PRIME Follow up - Quadri Meningo Vacinees : Meningococcal Disease : 2016-06-15 : Other: venepuncture only single venepuncture |
| Active, not recruiting |
: Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine : Meningococcal Disease : 2015-12-21 :
|
| Completed |
: A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) : Meningococcal Disease : 2015-05-04 : Biological: MenABCWY+OMV vaccine Intramuscular injection of a single dose at Day 1 to subjects in the Me |
| Active, not recruiting |
: Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations : Meningococcal Disease : 2015-05-13 : Biological: Menveo® Four Intramuscular doses of MenACWY vaccine at 2, 4, 6 and 12 months of age fol |
| Active, not recruiting |
: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study : Meningococcal Disease : 2014-10-27 : Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This study is strictly observational. D |
| Completed |
: Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents : Meningococcal Disease : 2014-11-05 :
|